Clinical Trials Logo

Filter by:
NCT ID: NCT05999175 Completed - Dental Plaque Clinical Trials

Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash

Start date: May 17, 2022
Phase: N/A
Study type: Interventional

The purpose of this open-label, randomized controlled clinical trial, is to provide preliminary clinical data (efficacy on plaque and gingival sensitivity, and safety and tolerability of two types of toothpaste, a mouthwash, and a specifically custom-designed toothbrush used for 28 days), as well as descriptive data on the effects of the products on oral microbiota rebalancing and patient acceptability. Eighty-four participants with a history of poor oral hygiene are visited at baseline and after 28 days of administration of the tested products. The control group consisted of 12 participants who continued to use their oral care products without changing their normal routine. At baseline and at the end of treatment (final visit), the oral microbiome is also evaluated in a group of 12 subjects allocated randomly.

NCT ID: NCT05991596 Completed - Vitiligo Clinical Trials

Vitiligo and Psychodrama Therapy

Start date: November 2, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot clinical trial is to assess the effectiveness of psychodramatic psychotherapy in reducing the psychological distress and/or the skin condition in patients with vitiligo. The main questions it aims to answer are: 1. Is there any improvement in terms of psychological distress in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? 2. Is there any improvement in terms of skin condition in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? Participants in the experimental group will receive the dermatological drug treatment usually recommended for vitiligo, and in addition they will participate in a 6 months psychodramatic psychotherapy. Researchers will compare the results of the experimental group with the results of a control group including vitiligo patients who will receive the dermatological pharmacological treatment usually recommended for vitiligo and participate in a 6 months program of self-help activities.

NCT ID: NCT05988346 Completed - Clinical trials for Diabetes Mellitus, Type 2

Ghrelin and Diastolic Heart Function

Start date: January 1, 2016
Phase:
Study type: Observational

In type 2 diabetes mellitus (T2DM) and obese patients the adipose tissue could over-express cytokines, sirtuin-1 (SIRT1), and microRNAs (miRs) implied in the regulation of left ventricle (LV) diastolic function (LV-DF). Ghrelin could modulate these pathways. Thus, in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision, and particularly in those with normalization of LV-DF at 1 year of follow-up.

NCT ID: NCT05987787 Completed - Clinical trials for Bariatric Surgery Candidate

Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy

Start date: January 1, 2022
Phase:
Study type: Observational

Staple line reinforcement (SLR) has been suggested as a mean of reducing the risk of sleeve leakage or bleeding. The aim of this study is to analyze if the suture reinforcement can be used to reduce the leakage rate after sleeve gastrectomy.

NCT ID: NCT05985837 Completed - Pharyngitis Clinical Trials

Post Market Clinical Follow-Up Study - Medical Device KalobaGOLA ( PMCF )

PMCF
Start date: August 2, 2023
Phase:
Study type: Observational

The goal of this observational PMCF study is to confirm the efficacy and safety of the medical device KalobaGola (oral spray and tablets) in children, adolescents and adults with sore throat and /or pharyngitis. The main questions it aims to answer are: - Is the product effective in the treatment of sore throat / pharyingits? - Is the product safe? After buying the product, participants will be asked to fill in a questionnaire, in order to: 1. Assess the sore throat symptoms before the use of the spray or tablets. 2. Assess the resolution of sore throat / pharyngitis symptoms after the use of the spray or tablets. 3. Describe the adverse effect(s)/problem(s) observed while using the product (if any).

NCT ID: NCT05985434 Completed - Clinical trials for Vertebral Metastasis

Prospective Observational Study on Vertebral Metastasis

CVODMetsVert
Start date: August 21, 2018
Phase:
Study type: Observational

Perspective observational cohort study in which the data relating to patients affected by one or more vertebral metastases or by vertebral localization of hemolifoproliferative malact and surgical treatment candidates will be collected, which will be recruited at the Complex Structure of Spine Surgery for Oncological and Degenerative Rizzoli Orthopedic Institute starting from the date of approval of the same study. Patients of both sexes and aged 18 years or older will be included. Patients with primary (benign or malignant) tumors of the vertebrae and patients unable to consent to the study will be excluded from the study. For each patient, in addition to the demographic data, preoperative information will be collected: type of tumor, involved vertebral levels, presence of pathological fracture, presence of visceral metastases, presence and number of other bone metastases, neurological picture according to Frankel's scale, evaluated pain according to the Visual Analogue Scale (VAS), functional status according to Karnofsky, EuroQoL-5D and SF-36 questionnaires on the quality of life; information related to the intervention itself: access, type of surgical treatment, possible preoperative embolization; intraoperative complications; information at discharge: postoperative complications, pain, neurological picture, functional status; follow-up data: pain, neurological picture, functional status, SF-36 questionnaire, late complications, local recurrence; systemic progression of the disease. Follow-up checks will be performed at 3 months, 6 months, 12 months, 18 months, 24 and 36 months. The timing of the controls and the examinations requested by the patients will be those of normal clinical practice. Primary endpoint is the change in quality of life (measured by scores EQ-5D and SF-36) and pain (measured using the VAS score) following surgery compared to pre-operative values.

NCT ID: NCT05984641 Completed - Hemorrhoid Pain Clinical Trials

Efficacy and Safety of CONAN® Proctological Cream for Treatment of Haemorrhoidal Disease

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Aim of the study is to assess the efficacy, safety and tolerability of CONAN® (Proctological Cream, Medical Device, Omikron Italia Srl) on most frequent symptoms in grade 1-2 of haemorrhoidal disease and anal fissures.

NCT ID: NCT05984095 Completed - Multiple Sclerosis Clinical Trials

Multiple Sclerosis Pelvic Floor Telerehabilitation

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of two different pelvic floor telerehabilitation protocols on selected measures of quality of life and health in females with relapsing-remitting Multiple Sclerosis (rrMS). The main questions it aims to answer are: - Is telerehabilitation sufficient to improve quality of life and health in females with rrMS, in particular dedicated to pelvic floor training? - Are self-administered training protocols or remotely-supervised training protocols equally effective? Participants will be randomized to two intervention groups: a self-administered training protocol (SELF) and a remotely-supervised (REMOTE) training protocol. Both protocols will consist in 10 sessions of pelvic floor training lasting 45 min each, once every 5 days. At the start and at the end of the protocol, all participants will complete 6 questionnaires regarding pain, quality of life and health.

NCT ID: NCT05981937 Completed - Anastomotic Leak Clinical Trials

ICG Anastomosis Control in Colon Surgery

Start date: July 20, 2023
Phase:
Study type: Observational

This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left colectomy including sigmoidectomy, splenic colic flexure resection). Secondary aims are to detect and to investigate the impact of various risk factors on AL and morbidity and surgical performance within 30 days to surgery.

NCT ID: NCT05978895 Completed - Clinical trials for Autism Spectrum Disorder

FOOD-AUT Pilot Study Canteen Menus for Adults With Autism Spectrum Disorder

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

The FOOD-AUT pilot study aimed to improve the health status of adults with Autism Spectrum Disorder (ASD) through a nutritional intervention at canteen service. The researchers adapted the canteen menus to the nutritional and sensory needs of this vulnerable population, reducing their food selectivity and improving their dietary diversity with a positive impact on their health. This project consisted of two phases: first an observational phase (Work Package 1, WP1) and secondarily an interventional phase (Work Package 2, WP2).